Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
20,707
archived clinical trials in
Gastrointestinal

Registry for Eosinophilic Gastrointestinal Disorders (REGID)
Registry for Eosinophilic Gastrointestinal Disorders (REGID)
Status: Enrolling
Updated:  7/30/2015
Univ of North Carolina
mi
from
Chapel Hill, NC
Registry for Eosinophilic Gastrointestinal Disorders (REGID)
Registry for Eosinophilic Gastrointestinal Disorders (REGID)
Status: Enrolling
Updated: 7/30/2015
Univ of North Carolina
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Registry for Eosinophilic Gastrointestinal Disorders (REGID)
Registry for Eosinophilic Gastrointestinal Disorders (REGID)
Status: Enrolling
Updated:  7/30/2015
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Registry for Eosinophilic Gastrointestinal Disorders (REGID)
Registry for Eosinophilic Gastrointestinal Disorders (REGID)
Status: Enrolling
Updated: 7/30/2015
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Registry for Eosinophilic Gastrointestinal Disorders (REGID)
Registry for Eosinophilic Gastrointestinal Disorders (REGID)
Status: Enrolling
Updated:  7/30/2015
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Registry for Eosinophilic Gastrointestinal Disorders (REGID)
Registry for Eosinophilic Gastrointestinal Disorders (REGID)
Status: Enrolling
Updated: 7/30/2015
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Registry for Eosinophilic Gastrointestinal Disorders (REGID)
Registry for Eosinophilic Gastrointestinal Disorders (REGID)
Status: Enrolling
Updated:  7/30/2015
Univ of Pennsylvania
mi
from
Philadelphia, PA
Registry for Eosinophilic Gastrointestinal Disorders (REGID)
Registry for Eosinophilic Gastrointestinal Disorders (REGID)
Status: Enrolling
Updated: 7/30/2015
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
ADAM-Afatinib Diarrhea Assessment and Management
A Phase IIIb, Non-randomized, Open-label, Two-cohort Study in Patients With EGFR Mutations-positive Advanced Adenocarcinoma of the Lung, Assessing the Utility of the Afatinib Diarrhea Assessment and Management Guidelines (ADAM)
Status: Enrolling
Updated:  7/30/2015
1199.15.10001 Boehringer Ingelheim Investigational Site
mi
from
Santa Rosa, CA
ADAM-Afatinib Diarrhea Assessment and Management
A Phase IIIb, Non-randomized, Open-label, Two-cohort Study in Patients With EGFR Mutations-positive Advanced Adenocarcinoma of the Lung, Assessing the Utility of the Afatinib Diarrhea Assessment and Management Guidelines (ADAM)
Status: Enrolling
Updated: 7/30/2015
1199.15.10001 Boehringer Ingelheim Investigational Site
mi
from
Santa Rosa, CA
Click here to add this to my saved trials
ADAM-Afatinib Diarrhea Assessment and Management
A Phase IIIb, Non-randomized, Open-label, Two-cohort Study in Patients With EGFR Mutations-positive Advanced Adenocarcinoma of the Lung, Assessing the Utility of the Afatinib Diarrhea Assessment and Management Guidelines (ADAM)
Status: Enrolling
Updated:  7/30/2015
Boehringer Ingelheim Investigational Site
mi
from
Orlando, FL
ADAM-Afatinib Diarrhea Assessment and Management
A Phase IIIb, Non-randomized, Open-label, Two-cohort Study in Patients With EGFR Mutations-positive Advanced Adenocarcinoma of the Lung, Assessing the Utility of the Afatinib Diarrhea Assessment and Management Guidelines (ADAM)
Status: Enrolling
Updated: 7/30/2015
Boehringer Ingelheim Investigational Site
mi
from
Orlando, FL
Click here to add this to my saved trials
ADAM-Afatinib Diarrhea Assessment and Management
A Phase IIIb, Non-randomized, Open-label, Two-cohort Study in Patients With EGFR Mutations-positive Advanced Adenocarcinoma of the Lung, Assessing the Utility of the Afatinib Diarrhea Assessment and Management Guidelines (ADAM)
Status: Enrolling
Updated:  7/30/2015
1200.45.056 Boehringer Ingelheim Investigational Site
mi
from
Port St. Lucie, FL
ADAM-Afatinib Diarrhea Assessment and Management
A Phase IIIb, Non-randomized, Open-label, Two-cohort Study in Patients With EGFR Mutations-positive Advanced Adenocarcinoma of the Lung, Assessing the Utility of the Afatinib Diarrhea Assessment and Management Guidelines (ADAM)
Status: Enrolling
Updated: 7/30/2015
1200.45.056 Boehringer Ingelheim Investigational Site
mi
from
Port St. Lucie, FL
Click here to add this to my saved trials
ADAM-Afatinib Diarrhea Assessment and Management
A Phase IIIb, Non-randomized, Open-label, Two-cohort Study in Patients With EGFR Mutations-positive Advanced Adenocarcinoma of the Lung, Assessing the Utility of the Afatinib Diarrhea Assessment and Management Guidelines (ADAM)
Status: Enrolling
Updated:  7/30/2015
1275.1.01117 Boehringer Ingelheim Investigational Site
mi
from
St. Petersburg, FL
ADAM-Afatinib Diarrhea Assessment and Management
A Phase IIIb, Non-randomized, Open-label, Two-cohort Study in Patients With EGFR Mutations-positive Advanced Adenocarcinoma of the Lung, Assessing the Utility of the Afatinib Diarrhea Assessment and Management Guidelines (ADAM)
Status: Enrolling
Updated: 7/30/2015
1275.1.01117 Boehringer Ingelheim Investigational Site
mi
from
St. Petersburg, FL
Click here to add this to my saved trials
ADAM-Afatinib Diarrhea Assessment and Management
A Phase IIIb, Non-randomized, Open-label, Two-cohort Study in Patients With EGFR Mutations-positive Advanced Adenocarcinoma of the Lung, Assessing the Utility of the Afatinib Diarrhea Assessment and Management Guidelines (ADAM)
Status: Enrolling
Updated:  7/30/2015
1199.14.1261 Boehringer Ingelheim Investigational Site
mi
from
Skokie, IL
ADAM-Afatinib Diarrhea Assessment and Management
A Phase IIIb, Non-randomized, Open-label, Two-cohort Study in Patients With EGFR Mutations-positive Advanced Adenocarcinoma of the Lung, Assessing the Utility of the Afatinib Diarrhea Assessment and Management Guidelines (ADAM)
Status: Enrolling
Updated: 7/30/2015
1199.14.1261 Boehringer Ingelheim Investigational Site
mi
from
Skokie, IL
Click here to add this to my saved trials
ADAM-Afatinib Diarrhea Assessment and Management
A Phase IIIb, Non-randomized, Open-label, Two-cohort Study in Patients With EGFR Mutations-positive Advanced Adenocarcinoma of the Lung, Assessing the Utility of the Afatinib Diarrhea Assessment and Management Guidelines (ADAM)
Status: Enrolling
Updated:  7/30/2015
1199.14.1261 Boehringer Ingelheim Investigational Site
mi
from
Skokie, IL
ADAM-Afatinib Diarrhea Assessment and Management
A Phase IIIb, Non-randomized, Open-label, Two-cohort Study in Patients With EGFR Mutations-positive Advanced Adenocarcinoma of the Lung, Assessing the Utility of the Afatinib Diarrhea Assessment and Management Guidelines (ADAM)
Status: Enrolling
Updated: 7/30/2015
1199.14.1261 Boehringer Ingelheim Investigational Site
mi
from
Skokie, IL
Click here to add this to my saved trials
ADAM-Afatinib Diarrhea Assessment and Management
A Phase IIIb, Non-randomized, Open-label, Two-cohort Study in Patients With EGFR Mutations-positive Advanced Adenocarcinoma of the Lung, Assessing the Utility of the Afatinib Diarrhea Assessment and Management Guidelines (ADAM)
Status: Enrolling
Updated:  7/30/2015
1200.167.01001 Boehringer Ingelheim Investigational Site
mi
from
Morristown, NJ
ADAM-Afatinib Diarrhea Assessment and Management
A Phase IIIb, Non-randomized, Open-label, Two-cohort Study in Patients With EGFR Mutations-positive Advanced Adenocarcinoma of the Lung, Assessing the Utility of the Afatinib Diarrhea Assessment and Management Guidelines (ADAM)
Status: Enrolling
Updated: 7/30/2015
1200.167.01001 Boehringer Ingelheim Investigational Site
mi
from
Morristown, NJ
Click here to add this to my saved trials
ADAM-Afatinib Diarrhea Assessment and Management
A Phase IIIb, Non-randomized, Open-label, Two-cohort Study in Patients With EGFR Mutations-positive Advanced Adenocarcinoma of the Lung, Assessing the Utility of the Afatinib Diarrhea Assessment and Management Guidelines (ADAM)
Status: Enrolling
Updated:  7/30/2015
205.452.01189 Boehringer Ingelheim Investigational Site
mi
from
Corvallis, OR
ADAM-Afatinib Diarrhea Assessment and Management
A Phase IIIb, Non-randomized, Open-label, Two-cohort Study in Patients With EGFR Mutations-positive Advanced Adenocarcinoma of the Lung, Assessing the Utility of the Afatinib Diarrhea Assessment and Management Guidelines (ADAM)
Status: Enrolling
Updated: 7/30/2015
205.452.01189 Boehringer Ingelheim Investigational Site
mi
from
Corvallis, OR
Click here to add this to my saved trials
ADAM-Afatinib Diarrhea Assessment and Management
A Phase IIIb, Non-randomized, Open-label, Two-cohort Study in Patients With EGFR Mutations-positive Advanced Adenocarcinoma of the Lung, Assessing the Utility of the Afatinib Diarrhea Assessment and Management Guidelines (ADAM)
Status: Enrolling
Updated:  7/30/2015
1199.15.10006 Boehringer Ingelheim Investigational Site
mi
from
Chattanooga, TN
ADAM-Afatinib Diarrhea Assessment and Management
A Phase IIIb, Non-randomized, Open-label, Two-cohort Study in Patients With EGFR Mutations-positive Advanced Adenocarcinoma of the Lung, Assessing the Utility of the Afatinib Diarrhea Assessment and Management Guidelines (ADAM)
Status: Enrolling
Updated: 7/30/2015
1199.15.10006 Boehringer Ingelheim Investigational Site
mi
from
Chattanooga, TN
Click here to add this to my saved trials
ADAM-Afatinib Diarrhea Assessment and Management
A Phase IIIb, Non-randomized, Open-label, Two-cohort Study in Patients With EGFR Mutations-positive Advanced Adenocarcinoma of the Lung, Assessing the Utility of the Afatinib Diarrhea Assessment and Management Guidelines (ADAM)
Status: Enrolling
Updated:  7/30/2015
1199.15.10006 Boehringer Ingelheim Investigational Site
mi
from
Chattanooga, TN
ADAM-Afatinib Diarrhea Assessment and Management
A Phase IIIb, Non-randomized, Open-label, Two-cohort Study in Patients With EGFR Mutations-positive Advanced Adenocarcinoma of the Lung, Assessing the Utility of the Afatinib Diarrhea Assessment and Management Guidelines (ADAM)
Status: Enrolling
Updated: 7/30/2015
1199.15.10006 Boehringer Ingelheim Investigational Site
mi
from
Chattanooga, TN
Click here to add this to my saved trials
ADAM-Afatinib Diarrhea Assessment and Management
A Phase IIIb, Non-randomized, Open-label, Two-cohort Study in Patients With EGFR Mutations-positive Advanced Adenocarcinoma of the Lung, Assessing the Utility of the Afatinib Diarrhea Assessment and Management Guidelines (ADAM)
Status: Enrolling
Updated:  7/30/2015
1200.71.1002 Boehringer Ingelheim Investigational Site
mi
from
Nashville, TN
ADAM-Afatinib Diarrhea Assessment and Management
A Phase IIIb, Non-randomized, Open-label, Two-cohort Study in Patients With EGFR Mutations-positive Advanced Adenocarcinoma of the Lung, Assessing the Utility of the Afatinib Diarrhea Assessment and Management Guidelines (ADAM)
Status: Enrolling
Updated: 7/30/2015
1200.71.1002 Boehringer Ingelheim Investigational Site
mi
from
Nashville, TN
Click here to add this to my saved trials
ADAM-Afatinib Diarrhea Assessment and Management
A Phase IIIb, Non-randomized, Open-label, Two-cohort Study in Patients With EGFR Mutations-positive Advanced Adenocarcinoma of the Lung, Assessing the Utility of the Afatinib Diarrhea Assessment and Management Guidelines (ADAM)
Status: Enrolling
Updated:  7/30/2015
Boehringer Ingelheim Investigational Site
mi
from
Richmond, VA
ADAM-Afatinib Diarrhea Assessment and Management
A Phase IIIb, Non-randomized, Open-label, Two-cohort Study in Patients With EGFR Mutations-positive Advanced Adenocarcinoma of the Lung, Assessing the Utility of the Afatinib Diarrhea Assessment and Management Guidelines (ADAM)
Status: Enrolling
Updated: 7/30/2015
Boehringer Ingelheim Investigational Site
mi
from
Richmond, VA
Click here to add this to my saved trials
RCT Comparing Methadone and Buprenorphine in Pregnant Women
Maternal Opioid Treatment: Human Experimental Research
Status: Enrolling
Updated:  7/30/2015
Johns Hopkins University School of Medicine
mi
from
Baltimore, MD
RCT Comparing Methadone and Buprenorphine in Pregnant Women
Maternal Opioid Treatment: Human Experimental Research
Status: Enrolling
Updated: 7/30/2015
Johns Hopkins University School of Medicine
mi
from
Baltimore, MD
Click here to add this to my saved trials
RCT Comparing Methadone and Buprenorphine in Pregnant Women
Maternal Opioid Treatment: Human Experimental Research
Status: Enrolling
Updated:  7/30/2015
Wayne State University
mi
from
Detroit, MI
RCT Comparing Methadone and Buprenorphine in Pregnant Women
Maternal Opioid Treatment: Human Experimental Research
Status: Enrolling
Updated: 7/30/2015
Wayne State University
mi
from
Detroit, MI
Click here to add this to my saved trials
RCT Comparing Methadone and Buprenorphine in Pregnant Women
Maternal Opioid Treatment: Human Experimental Research
Status: Enrolling
Updated:  7/30/2015
Thomas Jefferson University
mi
from
Philadelphia, PA
RCT Comparing Methadone and Buprenorphine in Pregnant Women
Maternal Opioid Treatment: Human Experimental Research
Status: Enrolling
Updated: 7/30/2015
Thomas Jefferson University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
RCT Comparing Methadone and Buprenorphine in Pregnant Women
Maternal Opioid Treatment: Human Experimental Research
Status: Enrolling
Updated:  7/30/2015
Brown University
mi
from
Providence, RI
RCT Comparing Methadone and Buprenorphine in Pregnant Women
Maternal Opioid Treatment: Human Experimental Research
Status: Enrolling
Updated: 7/30/2015
Brown University
mi
from
Providence, RI
Click here to add this to my saved trials
RCT Comparing Methadone and Buprenorphine in Pregnant Women
Maternal Opioid Treatment: Human Experimental Research
Status: Enrolling
Updated:  7/30/2015
Vanderbilt University
mi
from
Nashville, TN
RCT Comparing Methadone and Buprenorphine in Pregnant Women
Maternal Opioid Treatment: Human Experimental Research
Status: Enrolling
Updated: 7/30/2015
Vanderbilt University
mi
from
Nashville, TN
Click here to add this to my saved trials
RCT Comparing Methadone and Buprenorphine in Pregnant Women
Maternal Opioid Treatment: Human Experimental Research
Status: Enrolling
Updated:  7/30/2015
University of Vermont
mi
from
Burlington, VT
RCT Comparing Methadone and Buprenorphine in Pregnant Women
Maternal Opioid Treatment: Human Experimental Research
Status: Enrolling
Updated: 7/30/2015
University of Vermont
mi
from
Burlington, VT
Click here to add this to my saved trials
RCT Comparing Methadone and Buprenorphine in Pregnant Women
Maternal Opioid Treatment: Human Experimental Research
Status: Enrolling
Updated:  7/30/2015
Medical University of Vienna
mi
from
Vienna,
RCT Comparing Methadone and Buprenorphine in Pregnant Women
Maternal Opioid Treatment: Human Experimental Research
Status: Enrolling
Updated: 7/30/2015
Medical University of Vienna
mi
from
Vienna,
Click here to add this to my saved trials
Vitamin D Deficiency Causes Immune Dysfunction and Enables or Perpetuates the Development of Rheumatoid Arthritis
Vitamin D Deficiency Causes Immune Dysfunction and Enables or Perpetuates the Development of Rheumatoid Arthritis: Clinical Trial and Investigations on Dendritic Cells
Status: Enrolling
Updated:  7/31/2015
Indiana University
mi
from
Indianapolis, IN
Vitamin D Deficiency Causes Immune Dysfunction and Enables or Perpetuates the Development of Rheumatoid Arthritis
Vitamin D Deficiency Causes Immune Dysfunction and Enables or Perpetuates the Development of Rheumatoid Arthritis: Clinical Trial and Investigations on Dendritic Cells
Status: Enrolling
Updated: 7/31/2015
Indiana University
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated:  7/31/2015
Mayo Clinic Scottsdale
mi
from
Scottsdale, AZ
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/31/2015
Mayo Clinic Scottsdale
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated:  7/31/2015
Aurora Presbyterian Hospital
mi
from
Aurora, CO
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/31/2015
Aurora Presbyterian Hospital
mi
from
Aurora, CO
Click here to add this to my saved trials
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated:  7/31/2015
Boulder Community Hospital
mi
from
Boulder, CO
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/31/2015
Boulder Community Hospital
mi
from
Boulder, CO
Click here to add this to my saved trials
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated:  7/31/2015
Penrose Cancer Center at Penrose Hospital
mi
from
Colorado Springs, CO
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/31/2015
Penrose Cancer Center at Penrose Hospital
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated:  7/31/2015
Porter Adventist Hospital
mi
from
Denver, CO
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/31/2015
Porter Adventist Hospital
mi
from
Denver, CO
Click here to add this to my saved trials
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated:  7/31/2015
Rose Medical Center
mi
from
Denver, CO
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/31/2015
Rose Medical Center
mi
from
Denver, CO
Click here to add this to my saved trials
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated:  7/31/2015
St. Anthony Central Hospital
mi
from
Denver, CO
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/31/2015
St. Anthony Central Hospital
mi
from
Denver, CO
Click here to add this to my saved trials
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated:  7/31/2015
Presbyterian - St. Luke's Medical Center
mi
from
Denver, CO
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/31/2015
Presbyterian - St. Luke's Medical Center
mi
from
Denver, CO
Click here to add this to my saved trials
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated:  7/31/2015
Swedish Medical Center
mi
from
Englewood, CO
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/31/2015
Swedish Medical Center
mi
from
Englewood, CO
Click here to add this to my saved trials
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated:  7/31/2015
North Colorado Medical Center
mi
from
Greeley, CO
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/31/2015
North Colorado Medical Center
mi
from
Greeley, CO
Click here to add this to my saved trials
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated:  7/31/2015
Sky Ridge Medical Center
mi
from
Lone Tree, CO
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/31/2015
Sky Ridge Medical Center
mi
from
Lone Tree, CO
Click here to add this to my saved trials
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated:  7/31/2015
Hope Cancer Care Center at Longmont United Hospital
mi
from
Longmont, CO
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/31/2015
Hope Cancer Care Center at Longmont United Hospital
mi
from
Longmont, CO
Click here to add this to my saved trials
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated:  7/31/2015
McKee Medical Center
mi
from
Loveland, CO
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/31/2015
McKee Medical Center
mi
from
Loveland, CO
Click here to add this to my saved trials
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated:  7/31/2015
North Suburban Medical Center
mi
from
Thornton, CO
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/31/2015
North Suburban Medical Center
mi
from
Thornton, CO
Click here to add this to my saved trials
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated:  7/31/2015
Exempla Lutheran Medical Center
mi
from
Wheat Ridge, CO
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/31/2015
Exempla Lutheran Medical Center
mi
from
Wheat Ridge, CO
Click here to add this to my saved trials
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated:  7/31/2015
Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
mi
from
Hartford, CT
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/31/2015
Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
mi
from
Hartford, CT
Click here to add this to my saved trials
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated:  7/31/2015
Tunnell Cancer Center at Beebe Medical Center
mi
from
Lewes, DE
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/31/2015
Tunnell Cancer Center at Beebe Medical Center
mi
from
Lewes, DE
Click here to add this to my saved trials
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated:  7/31/2015
CCOP - Christiana Care Health Services
mi
from
Newark, DE
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/31/2015
CCOP - Christiana Care Health Services
mi
from
Newark, DE
Click here to add this to my saved trials
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated:  7/31/2015
MBCCOP - Medical College of Georgia Cancer Center
mi
from
Augusta, GA
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/31/2015
MBCCOP - Medical College of Georgia Cancer Center
mi
from
Augusta, GA
Click here to add this to my saved trials
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated:  7/31/2015
Kapiolani Medical Center at Pali Momi
mi
from
Aiea, HI
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/31/2015
Kapiolani Medical Center at Pali Momi
mi
from
Aiea, HI
Click here to add this to my saved trials
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated:  7/31/2015
OnCare Hawaii, Incorporated - Lusitana
mi
from
Honolulu, HI
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/31/2015
OnCare Hawaii, Incorporated - Lusitana
mi
from
Honolulu, HI
Click here to add this to my saved trials
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated:  7/31/2015
Cancer Research Center of Hawaii
mi
from
Honolulu, HI
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/31/2015
Cancer Research Center of Hawaii
mi
from
Honolulu, HI
Click here to add this to my saved trials
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated:  7/31/2015
Kapiolani Medical Center for Women and Children
mi
from
Honolulu, HI
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/31/2015
Kapiolani Medical Center for Women and Children
mi
from
Honolulu, HI
Click here to add this to my saved trials
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated:  7/31/2015
Hawaii Medical Center - East
mi
from
Honolulu, HI
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/31/2015
Hawaii Medical Center - East
mi
from
Honolulu, HI
Click here to add this to my saved trials
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated:  7/31/2015
Queen's Cancer Institute at Queen's Medical Center
mi
from
Honolulu, HI
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/31/2015
Queen's Cancer Institute at Queen's Medical Center
mi
from
Honolulu, HI
Click here to add this to my saved trials
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated:  7/31/2015
Tripler Army Medical Center
mi
from
Honolulu, HI
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/31/2015
Tripler Army Medical Center
mi
from
Honolulu, HI
Click here to add this to my saved trials